{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:10:15Z","timestamp":1792613415276,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T00:00:00Z","timestamp":1343433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Multiple myeloma (MM) is at present an incurable malignancy, characterized by apoptosis-resistant tumor cells. Interferon (IFN) treatment sensitizes MM cells to Fas-induced apoptosis and is associated with an increased activation of Signal transducer and activator of transcription (Stat)1. The role of Stat1 in MM has not been elucidated, but Stat1 has in several studies been ascribed a pro-apoptotic role. Conversely, IL-6 induction of Stat3 is known to confer resistance to apoptosis in MM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To delineate the role of Stat1 in IFN mediated sensitization to apoptosis, sub-lines of the U-266-1970 MM cell line with a stable expression of the active mutant Stat1C were utilized. The influence of Stat1C constitutive transcriptional activation on endogenous Stat3 expression and activation, and the expression of apoptosis-related genes were analyzed. To determine whether Stat1 alone would be an important determinant in sensitizing MM cells to apoptosis, the U-266-1970-Stat1C cell line and control cells were exposed to high throughput compound screening (HTS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>To explore the role of Stat1 in IFN mediated apoptosis sensitization of MM, we established sublines of the MM cell line U-266-1970 constitutively expressing the active mutant Stat1C. We found that constitutive nuclear localization and transcriptional activity of Stat1 was associated with an attenuation of IL-6-induced Stat3 activation and up-regulation of mRNA for the pro-apoptotic Bcl-2 protein family genes Harakiri, the short form of Mcl-1 and Noxa. However, Stat1 activation alone was not sufficient to sensitize cells to Fas-induced apoptosis. In a screening of &gt; 3000 compounds including bortezomib, dexamethasone, etoposide, suberoylanilide hydroxamic acid (SAHA), geldanamycin (17-AAG), doxorubicin and thalidomide, we found that the drug response and IC50 in cells constitutively expressing active Stat1 was mainly unaltered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We conclude that Stat1 alters IL-6 induced Stat3 activity and the expression of pro-apoptotic genes. However, this shift alone is not sufficient to alter apoptosis sensitivity in MM cells, suggesting that Stat1 independent pathways are operative in IFN mediated apoptosis sensitization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-12-318","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T14:14:38Z","timestamp":1343484878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma"],"prefix":"10.1186","volume":"12","author":[{"given":"Lina Y","family":"Dimberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Ivarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Frykn\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rickardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Gullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"\u00d6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Jernberg","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,28]]},"reference":[{"key":"3315_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrclinonc.2012.15","volume":"9","author":"A Mahindra","year":"2012","unstructured":"Mahindra A, Laubach J, Raje N, Munshi N, Richardson PG, Anderson K: Latest advances and current challenges in the treatment of multiple myeloma. Nat Rev Clin Oncol. 2012, 9: 135-143. 10.1038\/nrclinonc.2012.15.","journal-title":"Nat Rev Clin Oncol"},{"key":"3315_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/03009734.2012.659293","volume":"117","author":"H Jernberg-Wiklund","year":"2012","unstructured":"Jernberg-Wiklund H, Nilsson K: Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma. Ups J Med Sci. 2012, 117: 166-177. 10.3109\/03009734.2012.659293.","journal-title":"Ups J Med Sci"},{"key":"3315_CR3","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell","year":"1997","unstructured":"Darnell JE: STATs and gene regulation. Science. 1997, 277: 1630-1635. 10.1126\/science.277.5332.1630.","journal-title":"Science"},{"key":"3315_CR4","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/sj.onc.1203477","volume":"19","author":"TE Smithgall","year":"2000","unstructured":"Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB: Control of myeloid differentiation and survival by Stats. Oncogene. 2000, 19: 2612-2618. 10.1038\/sj.onc.1203477.","journal-title":"Oncogene"},{"key":"3315_CR5","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","volume":"19","author":"T Bowman","year":"2000","unstructured":"Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene. 2000, 19: 2474-2488. 10.1038\/sj.onc.1203527.","journal-title":"Oncogene"},{"key":"3315_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"R Catlett-Falcone","year":"1999","unstructured":"Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, et al: Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999, 10: 105-115. 10.1016\/S1074-7613(00)80011-4.","journal-title":"Immunity"},{"key":"3315_CR7","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2003-06-2151","volume":"103","author":"AC Bharti","year":"2004","unstructured":"Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB: Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood. 2004, 103: 3175-3184. 10.1182\/blood-2003-06-2151.","journal-title":"Blood"},{"issue":"Pt 2","key":"3315_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J. 1998, 334 (Pt 2): 297-314.","journal-title":"Biochem J"},{"key":"3315_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE: Stat3 as an oncogene. Cell. 1999, 98: 295-303. 10.1016\/S0092-8674(00)81959-5.","journal-title":"Cell"},{"key":"3315_CR10","first-page":"945","volume":"8","author":"R Buettner","year":"2002","unstructured":"Buettner R, Mora LB, Jove R: Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 2002, 8: 945-954.","journal-title":"Clin Cancer Res"},{"key":"3315_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.272.5262.719","volume":"272","author":"YE Chin","year":"1996","unstructured":"Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY: Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1\/CIP1 mediated by STAT1. Science. 1996, 272: 719-722. 10.1126\/science.272.5262.719.","journal-title":"Science"},{"key":"3315_CR12","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.278.5343.1630","volume":"278","author":"A Kumar","year":"1997","unstructured":"Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR: Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science. 1997, 278: 1630-1632. 10.1126\/science.278.5343.1630.","journal-title":"Science"},{"key":"3315_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0014-5793(99)01283-1","volume":"459","author":"KY Lee","year":"1999","unstructured":"Lee KY, Anderson E, Madani K, Rosen GD: Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells. FEBS Lett. 1999, 459: 323-326. 10.1016\/S0014-5793(99)01283-1.","journal-title":"FEBS Lett"},{"key":"3315_CR14","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.1074\/jbc.275.14.10002","volume":"275","author":"A Stephanou","year":"2000","unstructured":"Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS, Knight RA, Latchman DS: Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem. 2000, 275: 10002-10008. 10.1074\/jbc.275.14.10002.","journal-title":"J Biol Chem"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/onc.2009.142","volume":"28","author":"K Bauer","year":"2009","unstructured":"Bauer K, Kretzschmar AK, Cvijic H, Blumert C, Loffler D, Brocke-Heidrich K, Schiene-Fischer C, Fischer G, Sinz A, Clevenger CV, Horn F: Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells. Oncogene. 2009, 28: 2784-2795. 10.1038\/onc.2009.142.","journal-title":"Oncogene"},{"key":"3315_CR16","doi-asserted-by":"publisher","first-page":"41679","DOI":"10.1074\/jbc.M406413200","volume":"279","author":"Y Qing","year":"2004","unstructured":"Qing Y, Stark GR: Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem. 2004, 279: 41679-41685. 10.1074\/jbc.M406413200.","journal-title":"J Biol Chem"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1073\/pnas.122236099","volume":"99","author":"AP Costa-Pereira","year":"2002","unstructured":"Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is'harc H, Gesualdo I, Newman SJ, Kerr IM, Poli V: Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A. 2002, 99: 8043-8047. 10.1073\/pnas.122236099.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3315_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.cdd.4400656","volume":"7","author":"A Stephanou","year":"2000","unstructured":"Stephanou A, Brar BK, Knight RA, Latchman DS: Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 2000, 7: 329-330. 10.1038\/sj.cdd.4400656.","journal-title":"Cell Death Differ"},{"key":"3315_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1517\/13543776.2011.539205","volume":"21","author":"BD Page","year":"2011","unstructured":"Page BD, Ball DP, Gunning PT: Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opin Ther Pat. 2011, 21: 65-83. 10.1517\/13543776.2011.539205.","journal-title":"Expert Opin Ther Pat"},{"key":"3315_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-11-12","volume":"11","author":"I Souissi","year":"2012","unstructured":"Souissi I, Ladam P, Cognet JA, Le Coquil S, Varin-Blank N, Baran-Marszak F, Metelev V, Fagard R: A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line. Mol Cancer. 2012, 11: 12-10.1186\/1476-4598-11-12.","journal-title":"Mol Cancer"},{"key":"3315_CR21","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood.V92.8.2914","volume":"92","author":"H Spets","year":"1998","unstructured":"Spets H, Georgii-Hemming P, Siljason J, Nilsson K, Jernberg-Wiklund H: Fas\/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. Blood. 1998, 92: 2914-2923.","journal-title":"Blood"},{"key":"3315_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2004-04-1322","volume":"106","author":"LY Dimberg","year":"2005","unstructured":"Dimberg LY, Dimberg AI, Ivarsson K, Stromberg T, Osterborg A, Nilsson K, Oberg F, Jernberg Wiklund H: Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells. Blood. 2005, 106: 1346-1354. 10.1182\/blood-2004-04-1322.","journal-title":"Blood"},{"key":"3315_CR23","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1074\/jbc.M307774200","volume":"279","author":"JJ Sironi","year":"2004","unstructured":"Sironi JJ, Ouchi T: STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem. 2004, 279: 4066-4074.","journal-title":"J Biol Chem"},{"key":"3315_CR24","first-page":"310","volume":"6","author":"H Jernberg-Wiklund","year":"1992","unstructured":"Jernberg-Wiklund H, Pettersson M, Carlsson M, Nilsson K: Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia. 1992, 6: 310-318.","journal-title":"Leukemia"},{"key":"3315_CR25","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/j.1460-2075.1993.tb06106.x","volume":"12","author":"M Muller","year":"1993","unstructured":"Muller M, Laxton C, Briscoe J, Schindler C, Improta T, Darnell JE, Stark GR, Kerr IM: Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. Embo J. 1993, 12: 4221-4228.","journal-title":"Embo J"},{"key":"3315_CR26","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/blood.V96.8.2870","volume":"96","author":"A Dimberg","year":"2000","unstructured":"Dimberg A, Nilsson K, Oberg F: Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood. 2000, 96: 2870-2878.","journal-title":"Blood"},{"key":"3315_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/nar\/19.9.2499","volume":"19","author":"NC Andrews","year":"1991","unstructured":"Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991, 19: 2499-10.1093\/nar\/19.9.2499.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1128\/MCB.11.1.182","volume":"11","author":"DJ Lew","year":"1991","unstructured":"Lew DJ, Decker T, Strehlow I, Darnell JE: Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol. 1991, 11: 182-191.","journal-title":"Mol Cell Biol"},{"key":"3315_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mrd.1080340206","volume":"34","author":"E Nilsson","year":"1993","unstructured":"Nilsson E, Lendahl U: Transient expression of a human beta-actin promoter\/lacZ gene introduced into mouse embryos correlates with a low degree of methylation. Mol Reprod Dev. 1993, 34: 149-157. 10.1002\/mrd.1080340206.","journal-title":"Mol Reprod Dev"},{"key":"3315_CR30","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30: e57-10.1093\/nar\/gnf056.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR31","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1093\/nar\/gng153","volume":"31","author":"E Eldering","year":"2003","unstructured":"Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF, McElgunn CJ, Schouten JP: Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res. 2003, 31: e153-10.1093\/nar\/gng153.","journal-title":"Nucleic Acids Res"},{"key":"3315_CR32","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","volume":"267","author":"J O'Brien","year":"2000","unstructured":"O'Brien J, Wilson I, Orton T, Pognan F: Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000, 267: 5421-5426. 10.1046\/j.1432-1327.2000.01606.x.","journal-title":"Eur J Biochem"},{"key":"3315_CR33","first-page":"473","volume":"3","author":"B Pag\u00e9","year":"1993","unstructured":"Pag\u00e9 B, Pag\u00e9 M, Noel C: A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol. 1993, 3: 473-476.","journal-title":"Int J Oncol"},{"key":"3315_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ijc.2910500204","volume":"50","author":"R Larsson","year":"1992","unstructured":"Larsson R, Kristensen J, Sandberg C, Nygren P: Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int J Cancer. 1992, 50: 177-185. 10.1002\/ijc.2910500204.","journal-title":"Int J Cancer"},{"key":"3315_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00280-006-0216-7","volume":"58","author":"L Rickardson","year":"2006","unstructured":"Rickardson L, Fryknas M, Haglund C, Lovborg H, Nygren P, Gustafsson MG, Isaksson A, Larsson R: Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Cancer Chemother Pharmacol. 2006, 58: 749-758. 10.1007\/s00280-006-0216-7.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3315_CR36","first-page":"316","volume":"9","author":"S Alas","year":"2003","unstructured":"Alas S, Bonavida B: Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis. Clin Cancer Res. 2003, 9: 316-326.","journal-title":"Clin Cancer Res"},{"key":"3315_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1365-2141.2000.02127.x","volume":"109","author":"J De Vos","year":"2000","unstructured":"De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B: JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol. 2000, 109: 823-828. 10.1046\/j.1365-2141.2000.02127.x.","journal-title":"Br J Haematol"},{"key":"3315_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0955-0674(00)00199-X","volume":"13","author":"JN Ihle","year":"2001","unstructured":"Ihle JN: The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001, 13: 211-217. 10.1016\/S0955-0674(00)00199-X.","journal-title":"Curr Opin Cell Biol"},{"key":"3315_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08977190500178745","volume":"23","author":"A Stephanou","year":"2005","unstructured":"Stephanou A, Latchman DS: Opposing actions of STAT-1 and STAT-3. Growth Factors. 2005, 23: 177-182. 10.1080\/08977190500178745.","journal-title":"Growth Factors"},{"key":"3315_CR40","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1172\/JCI0215841","volume":"110","author":"F Hong","year":"2002","unstructured":"Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, Nguyen VA, Gao B: Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest. 2002, 110: 1503-1513.","journal-title":"J Clin Invest"},{"key":"3315_CR41","doi-asserted-by":"publisher","first-page":"63E","DOI":"10.1016\/j.amjcard.2008.03.003","volume":"101","author":"TM Scarabelli","year":"2008","unstructured":"Scarabelli TM, Townsend PA, Chen-Scarabelli C, Yuan Z, McCauley RB, Di Rezze J, Patel D, Putt J, Allebban Z, Abboud J, et al: Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia\/reperfusion injury. Am J Cardiol. 2008, 101: 63E-68E.","journal-title":"Am J Cardiol"},{"key":"3315_CR42","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1016\/j.yexcr.2007.08.007","volume":"313","author":"L Thyrell","year":"2007","unstructured":"Thyrell L, Arulampalam V, Hjortsberg L, Farnebo M, Grander D: Pokrovskaja Tamm K: Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity. Exp Cell Res. 2007, 313: 4015-4024. 10.1016\/j.yexcr.2007.08.007.","journal-title":"Exp Cell Res"},{"key":"3315_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","volume":"23","author":"JF Bromberg","year":"2001","unstructured":"Bromberg JF: Activation of STAT proteins and growth control. Bioessays. 2001, 23: 161-169. 10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0.","journal-title":"Bioessays"},{"key":"3315_CR44","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4161\/cc.3.10.1196","volume":"3","author":"S Le Gouill","year":"2004","unstructured":"Le Gouill S, Podar K, Harousseau JL, Anderson KC: Mcl-1 regulation and its role in multiple myeloma. Cell Cycle. 2004, 3: 1259-1262. 10.4161\/cc.3.10.1196.","journal-title":"Cell Cycle"},{"key":"3315_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V100.1.194","volume":"100","author":"S Derenne","year":"2002","unstructured":"Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL, Bataille R, Amiot M: Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood. 2002, 100: 194-199. 10.1182\/blood.V100.1.194.","journal-title":"Blood"},{"key":"3315_CR46","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/emboj\/16.7.1686","volume":"16","author":"N Inohara","year":"1997","unstructured":"Inohara N, Ding L, Chen S, Nunez G: harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). Embo J. 1997, 16: 1686-1694. 10.1093\/emboj\/16.7.1686.","journal-title":"Embo J"},{"key":"3315_CR47","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1074\/jbc.M302637200","volume":"279","author":"PA Townsend","year":"2004","unstructured":"Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A: STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem. 2004, 279: 5811-5820.","journal-title":"J Biol Chem"},{"key":"3315_CR48","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1101\/gad.1103603","volume":"17","author":"T Shibue","year":"2003","unstructured":"Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A, Morishita Y, Akira S, Taniguchi T, Tanaka N: Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 2003, 17: 2233-2238. 10.1101\/gad.1103603.","journal-title":"Genes Dev"},{"key":"3315_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.22291","volume":"120","author":"M Fryknas","year":"2007","unstructured":"Fryknas M, Dhar S, Oberg F, Rickardson L, Rydaker M, Goransson H, Gustafsson M, Pettersson U, Nygren P, Larsson R, Isaksson A: STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer. 2007, 120: 189-195. 10.1002\/ijc.22291.","journal-title":"Int J Cancer"},{"key":"3315_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1073\/pnas.0308102100","volume":"101","author":"NN Khodarev","year":"2004","unstructured":"Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR: STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A. 2004, 101: 1714-1719. 10.1073\/pnas.0308102100.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-318\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:48:11Z","timestamp":1630615691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-318","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,28]]},"assertion":[{"value":"12 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"318"}}